Andrew Perkins


Accepting PhD Students

PhD projects

1. Direct targets of JAK-STAT signaling in blood cancers 2. Transcriptional Networks in Erythropoiesis 3. Gene editing to cure inherited blood cell disorders 4. Genomics and personalised medicine for blood cancers

1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Andrew Perkins 

Perkins Group - Blood Cancer Genomics

Andrew is a Professor in the Australian Centre for Blood Diseases, within the Central Clinical School. Dr Perkins trained at RPA Hospital in Sydney in clinical and laboratory haematology, undertook his PhD in genetics at Walter and Eliza Hall Institute, then post-doctoral studies at Harvard University before returning to Australia in 1997.

Professor Perkins is a clinician-scientist who seeks to understand transcriptional control networks which underpin normal blood stem cell production and blood cancers. We intend to harness this knowledge to cure inherited or acquired human blood diseases.




Supervision interests

Extensive experience in RHD supervision:

22 PhD students

24 BSc Hons students

5 Masters students

1 BSc (Med) student


Clinical activities

Senior Medical Officer in Haematology at The Alfred Hospital in Melbourne

Clinical Lead in Myeloproliferative Neoplasms including Myelofibrosis

Monash teaching commitment

Teaching in HUP3022 - Haematological Malignancies

Teaching in HUP3990 - Third Year Research Projects

Community service

Scientific Advisory Board of Captain Courageous Foundation

Australia Leukaemia and Lymphoma Group Subcommittee for Myeloproliferative Neoplasms

Lorne Genome Organising Committee 2016-2020

NHMRC GRPs in Oncology and Biochemistry 2007-2018

NHMRC Investigator Grant Review Panel 2020

External positions

Pathologist (Department of Pathology), Alfred Health

1 Dec 2017 → …

Professor of Haematology, Alfred Health

3 Jul 2017 → …

University of Queensland

Research area keywords

  • KLF1
  • Erythropoiesis
  • Myelodysplasia
  • Leukaemia
  • Transcription factors
  • Genome Editing
  • Genomics
  • Cancer Cell Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance

Barbier, V., Erbani, J., Fiveash, C., Davies, J. M., Tay, J., Tallack, M. R., Lowe, J., Magnani, J. L., Pattabiraman, D. R., Perkins, A. C., Lisle, J., Rasko, J. E. J., Levesque, J. P. & Winkler, I. G., 27 Apr 2020, In : Nature Communications. 11, 1, 15 p., 2042.

Research output: Contribution to journalArticleResearchpeer-review

Open Access

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors (Scientific Reports, (2018), 8, 1, (12457), 10.1038/s41598-018-29865-x)

Cheung Tung Shing, K. S., Broughton, S. E., Nero, T. L., Gillinder, K., Ilsley, M. D., Ramshaw, H., Lopez, A. F., Griffin, M. D. W., Parker, M. W., Perkins, A. C. & Dhagat, U., 1 Dec 2019, In : Scientific Reports. 9, 1, 3 p., 7851.

Research output: Contribution to journalComment / DebateOtherpeer-review

Open Access

Corrupted DNA-binding specificity and ectopic transcription underpin dominant neomorphic mutations in KLF/SP transcription factors

Ilsley, M. D., Huang, S., Magor, G. W., Landsberg, M. J., Gillinder, K. R. & Perkins, A. C., 24 May 2019, In : BMC Genomics. 20, 1, 12 p., 417.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
1 Citation (Scopus)

Genetic Variants Within the Erythroid Transcription Factor, KLF1, and Reduction of the Expression of Lutheran and Other Blood Group Antigens: Review of the In(Lu)Phenotype

Fraser, N. S., Knauth, C. M., Moussa, A., Dean, M. M., Hyland, C. A., Perkins, A. C., Flower, R. L. & Schoeman, E. M., 1 Apr 2019, In : Transfusion Medicine Reviews. 33, 2, p. 111-117 7 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR

Bisht, K., Brunck, M. E., Matsumoto, T., McGirr, C., Nowlan, B., Fleming, W., Keech, T., Magor, G., Perkins, A. C., Davies, J., Walkinshaw, G., Flippin, L., Winkler, I. G. & Levesque, J. P., 12 Feb 2019, In : Blood Advances. 3, 3, p. 406-418 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
1 Citation (Scopus)


Albert G. Baikie Memorial Medal

Perkins, Andrew (Recipient), 1991

Prize: Prize (including medals and awards)

AMRAD Postdoctoral Award

Perkins, Andrew (Recipient), 1997

Prize: Prize (including medals and awards)

Logan Research Fellowship

Perkins, Andrew (Recipient), 1997

Prize: Competitive Fellowships

Lucille P. Markey Postdoctoral Research Fellowship

Perkins, Andrew (Recipient), 1993

Prize: Competitive Fellowships

Medical Postgraduate Research Fellowship

Perkins, Andrew (Recipient), 1989

Prize: Competitive Fellowships


Centre for Cancer Biology

Andrew Perkins (Visiting researcher)

12 Sep 2019

Activity: Visiting an external institution typesVisiting an external academic institution

Lorne Genome Conference 2019

Andrew Perkins (Organiser)

17 Feb 201919 Feb 2019

Activity: Participating in or organising an event typesContribution to conference

Novartis Oncology (External organisation)

Andrew Perkins (Member)

21 Feb 2019

Activity: Industry, Government and Philanthropy Engagement and PartnershipsConsultancy

Investigator Grant Panel Committee Member

Andrew Perkins (Executive Member)

Mar 2019May 2019

Activity: External Academic EngagementPeer review panel or committee

Gordon Research Conference on Red Cells

Andrew Perkins (Invited speaker)

14 Jul 201919 Jul 2019

Activity: Participating in or organising an event typesContribution to conference